Reactive Lymphadenopathies: Molecular Analysis

  • Dennis P. O’Malley
Part of the Molecular Pathology Library book series (MPLB, volume 4)


The molecular analysis of benign and reactive processes in lymph nodes is important in several contexts. In terms of research into underlying pathophysiology, molecular analyzes of clonality may be crucial in establishing that a rare or enigmatic process, such as Rosai–Dorfman disease, is a non-clonal proliferative lesion. In addition, molecular testing for the presence of infectious agents may be critical in evaluating the causative effects of these infections in benign and reactive processes.


Follicular Lymphoma Mycosis Fungoides Marginal Zone Lymphoma Follicular Hyperplasia Splenic Marginal Zone Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hummel M, Stein H. Clonality and malignancy. PCR assays for the diagnosis of clonal B- and T-cell proliferations: potentials and pitfalls. Verh Dtsch Ges Pathol. 2003;87:102–108.PubMedGoogle Scholar
  2. 2.
    Thériault C, Galoin S, Valmary S, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol. 2000;13:1269–1279.CrossRefPubMedGoogle Scholar
  3. 3.
    De Re V, De Vita S, Carbone A, et al. The relevance of VDJ PCR protocols in detecting B-cell clonal expansion in lymphomas and other lymphoproliferative disorders. Tumori. 1995;81:405–409.PubMedGoogle Scholar
  4. 4.
    Tbakhi A, Totos G, Pettay JD, et al. The effect of fixation on detection of B-cell clonality by polymerase chain reaction. Mod Pathol. 1999;12:272–278.PubMedGoogle Scholar
  5. 5.
    Iijima T, Inadome Y, Noguchi M. Clonal proliferation of B lymphocytes in the germinal centers of human reactive lymph nodes: possibility of overdiagnosis of B cell clonal proliferation. Diagn Mol Pathol. 2000;9:132–136.CrossRefPubMedGoogle Scholar
  6. 6.
    Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren’s syndrome) begin as nonmalignant antigen-selected expansions. Blood. 1998;91:1864–1872.PubMedGoogle Scholar
  7. 7.
    Itoh K, Patki V, Furie RA, et al. Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis. Arthritis Res. 2000;2:50–58.CrossRefPubMedGoogle Scholar
  8. 8.
    Saxena A, Alport EC, Moshynska O, et al. Clonal B cell populations in a minority of patients with Hashimoto’s thyroiditis. J Clin Pathol. 2004;57:1258–1263.CrossRefPubMedGoogle Scholar
  9. 9.
    Engels K, Oeschger S, Hansmann ML, et al. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates. Hum Pathol. 2007;38:1402–1411.CrossRefPubMedGoogle Scholar
  10. 10.
    Lonergan CL, Lentzner AN, Hartmann CJ, et al. Clonal bands are readily demonstrable in benign follicles individually excised from paraffin blocks utilizing PCR for amplification of IgH gene regions [abstract]. Mod Pathol. 2002;15:251A.Google Scholar
  11. 11.
    Limpens J, de Jong D, van Krieken JH, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene. 1991;6:2271–2276.PubMedGoogle Scholar
  12. 12.
    Aster JC, Kobayashi Y, Shiota M, et al. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol. 1992;141:291–299.PubMedGoogle Scholar
  13. 13.
    Ohshima K, Kikuchi M, Kobari S, et al. Amplified bcl-2/JH rearrangements in reactive lymphadenopathy. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63:197–198.CrossRefPubMedGoogle Scholar
  14. 14.
    Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 1995;85:2528–2536.PubMedGoogle Scholar
  15. 15.
    Rauzy O, Galoin S, Chale JJ, et al. Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases. Mol Pathol. 1998;51:333–338.PubMedGoogle Scholar
  16. 16.
    Dölken G, Illerhaus G, Hirt C, et al. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol. 1996;14:1333–1344.PubMedGoogle Scholar
  17. 17.
    Tsimberidou AM, Jiang Y, Ford RJ, et al. Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma. Leuk Lymphoma. 2002;43:1589–1598.CrossRefPubMedGoogle Scholar
  18. 18.
    Schmitt C, Balogh B, Grundt A, et al. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Leuk Res. 2006;30:745–750.CrossRefPubMedGoogle Scholar
  19. 19.
    Kojima M, Nakamura S, Tanaka H, et al. Massive hyperplasia of marginal zone B-cells with clear cytoplasm in the lymph node: a case report. Pathol Res Pract. 2003;199:625–628.CrossRefPubMedGoogle Scholar
  20. 20.
    Kojima M, Motoori T, Iijima M, et al. Florid monocytoid B-cell hyperplasia resembling nodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type. A histological and immunohistochemical study of four cases. Pathol Res Pract. 2006;202:877–882.CrossRefPubMedGoogle Scholar
  21. 21.
    Farhi DC, Ashfaq R. Splenic pathology after traumatic injury. Am J Clin Pathol. 1996;105:474–478.PubMedGoogle Scholar
  22. 22.
    Kroft SH, Singleton TP, Dahiya M, et al. Ruptured spleens with expanded marginal zones do not reveal occult B-cell clones. Mod Pathol. 1997;10:1214–1220.PubMedGoogle Scholar
  23. 23.
    Dunphy CH, Bee C, McDonald JW, et al. Incidental early detection of a splenic marginal zone lymphoma by polymerase chain reaction analysis of paraffin-embedded tissue. Arch Pathol Lab Med. 1998;122:84–86.PubMedGoogle Scholar
  24. 24.
    Attygalle AD, Liu H, Shirali S, et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood. 2004;104:3343–3348.CrossRefPubMedGoogle Scholar
  25. 25.
    Jones D. Dismantling the germinal center: comparing the processes of transformation, regression, and fragmentation of the lymphoid follicle. Adv Anat Pathol. 2002;9:129–138.CrossRefPubMedGoogle Scholar
  26. 26.
    Chang CC, Osipov V, Wheaton S, et al. Follicular hyperplasia, follicular lysis, and progressive transformation of germinal centers. A sequential spectrum of morphologic evolution in lymphoid hyperplasia. Am J Clin Pathol. 2003;120:322–326.CrossRefPubMedGoogle Scholar
  27. 27.
    Lee SC, Berg KD, Racke FK, et al. Pseudo-spikes are common in histologically benign lymphoid tissues. J Mol Diagn. 2000;2:145–152.PubMedGoogle Scholar
  28. 28.
    O’Malley DP. T-cell large granular leukemia and related proliferations. Am J Clin Pathol. 2007;127:850–859.CrossRefPubMedGoogle Scholar
  29. 29.
    Assaf C, Hummel M, Steinhoff M, et al. Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. Blood. 2005;105:503–510.CrossRefPubMedGoogle Scholar
  30. 30.
    Olsen E, Vondereheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of research and Treatment of Cancer (EORTC). Blood. 2007;110:1713–1722.CrossRefPubMedGoogle Scholar
  31. 31.
    Onciu M, Medeiros LJ. Kikuchi–Fujimoto lymphadenitis. Adv Anat Pathol. 2003;10:204–211.CrossRefPubMedGoogle Scholar
  32. 32.
    Hollingsworth HC, Peiper SC, Weiss LM, et al. An investigation of the viral pathogenesis of Kikuchi–Fujimoto disease. Lack of evidence for Epstein–Barr virus or human herpesvirus type 6 as the causative agents. Arch Pathol Lab Med. 1994;118:134–140.PubMedGoogle Scholar
  33. 33.
    Cho KJ, Lee SS, Khang SK. Histiocytic necrotizing lymphadenitis. A clinico-pathologic study of 45 cases with in situ hybridization for Epstein–Barr virus and hepatitis B virus. J Korean Med Sci. 1996;11:409–414.PubMedGoogle Scholar
  34. 34.
    George TI, Jones CD, Zehnder JL, et al. Lack of human herpesvirus 8 and Epstein–Barr virus in Kikuchi’s histiocytic necrotizing lymphadenitis. Hum Pathol. 2003;34:130–135.CrossRefPubMedGoogle Scholar
  35. 35.
    Chim CS, Shek W, Liang R, et al. Kimura’s disease: no evidence of clonality. Br J Ophthalmol. 1999;83:880–881.CrossRefPubMedGoogle Scholar
  36. 36.
    Jang KA, Ahn SJ, Choi JH, et al. Polymerase chain reaction (PCR) for human herpesvirus 8 and heteroduplex PCR for clonality assessment in angiolymphoid hyperplasia with eosinophilia and Kimura’s disease. J Cutan Pathol. 2001;28:363–367.CrossRefPubMedGoogle Scholar
  37. 37.
    Chim CS, Fung A, Shek TW, et al. Analysis of clonality in Kimura’s disease. Am J Surg Pathol. 2002;26:1083–1086.CrossRefPubMedGoogle Scholar
  38. 38.
    Chim CS, Liang R, Fung A, et al. Further analysis of clonality in Kimura’s disease. Am J Surg Pathol. 2003;27:703–704.CrossRefPubMedGoogle Scholar
  39. 39.
    Nagore E, Llorca J, Sánchez-Motilla JM, et al. Detection of Epstein–Barr virus DNA in a patient with Kimura’s disease. Int J Dermatol. 2000;39:618–620.CrossRefPubMedGoogle Scholar
  40. 40.
    McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program. 2004;283–296.Google Scholar
  41. 41.
    Paulli M, Bergamaschi G, Tonon L, et al. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease). Br J Haematol. 1995;91:415–418.CrossRefPubMedGoogle Scholar
  42. 42.
    Maric I, Pittaluga S, Dale JK, et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol. 2005;29:903-911.PubMedGoogle Scholar
  43. 43.
    Olive C, Gatenby PA, Serjeantson SW. Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol. 1994;97(3):430–438.CrossRefPubMedGoogle Scholar
  44. 44.
    Masuko-Hongo K, Kato T, Suzuki S, et al. Frequent clonal expansion of peripheral T cells in patients with autoimmune diseases: a novel detecting system possibly applicable to laboratory examination. J Clin Lab Anal. 1998;12(3):162–167.CrossRefPubMedGoogle Scholar
  45. 45.
    Jordan R, Diss TC, Lench NJ, et al. Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren’s syndrome. A possible predictor of lymphoma development. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:723–729.CrossRefPubMedGoogle Scholar
  46. 46.
    Harris NL, Swerdlow SH. Methotrexate-associated lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2001:270–271.Google Scholar
  47. 47.
    Paul C, Le Tourneau A, Cayuela JM, et al. Epstein–Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol. 1997;133:867–871.CrossRefPubMedGoogle Scholar
  48. 48.
    Abbondazo SL, Irey NS, Frizzera G. Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns. Am J Surg Pathol. 1995;19:675–686.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Dennis P. O’Malley
    • 1
  1. 1.Hematopathologist, Clarient Inc.Aliso ViejoUSA

Personalised recommendations